Search results
BioMarin was founded in 1997 by Christopher Starr Ph.D. and Grant W. Denison Jr. with an investment of a $1.5 million from Glyko Biomedical and went public in 1999. Seed investors were amongst others MPM Bioventures, Grosvenor Fund and Florian Schönharting.
View Grant Denison’s profile on LinkedIn, a professional community of 1 billion members. Founder and former CEO BioMarin, consultant, strategist and catalyst for change in biopharmaceuticals...
Nov 20, 2020 · BioMarin was founded by Christopher Starr and Grant W. Denison Jr. with an initial investment of $1.5 million that came from Glyko Biomedical Ltd. The company was further successful in raising...
Jan 27, 2020 · Grant Denison Jr., 70, passed away Wednesday, January 23, 2020 in his home in Sonoma, California. He was born on June 28th, 1949 in Connecticut to Grant and Florence Denison. He attended Colgate University as an undergraduate before going on to Harvard Business School, graduating with his MBA in 1973.
Nov 16, 2020 · Headquarters: California, USA Employees: 3,001 Founded: 1997 by Christopher Starr Ph.D. and Grant W. Denison Jr. IPO: listed in July 1999 at $13, raised $67.3m. BioMarin is a global biotechnology...
Grant Denison Jr., 70, passed away Wednesday, January 23, 2020 in his home in Sonoma, California. He was born on June 28th, 1949 in Connecticut to Grant and Florence Denison. He attended Colgate University as an undergraduate before going on to Harvard Business School, graduating with his MBA in 1973.
Nov 4, 2000 · BIOMARIN PHARMACEUTICAL, Novato, Calif., named Fredric D. Price chairman and chief executive, succeeding Grant W. Denison Jr., who continues to serve on the board. Mr. Price had been president...
